WINSTON TAYLOR LLP (FORMERLY KNOWN AS WINSTON & STRAWN LLP) for BARR LABORATORIES INC
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Development of a biogeneric drug approval framework (S.1695; H.R. 1956); Issues affecting pharmaceuticals, including: Settlements legislation, S.316; patent reform legislation (H.R. 1908 and S.1145); authorized generics (H.R. 806; S.1082); FDA reform and regulation, and the federal drug approval process for generic drugs (S.1082; H.R. 3580); appropriations for the FDA Office of Generic Drug Approval (H.R. 3161; S.1859; H.R. 2764); opposition to legislation proposing patent filing deadline
| Lobbyist | Covered position, as disclosed |
|---|---|
| WESLEY BIZZELL | — |
| CHARLES L KINNEY | N/A |
| JOHN D MCMICKLE | N/A |
| JOHN A WAITS | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.